© 1996 British Society for Rheumatology
research-article |
EXPRESSION OF CYCLOOXYGENASE-2 IN HUMAN AND AN ANIMAL MODEL OF RHEUMATOID ARTHRITIS
Syntex Discovery Research, Institute of Immunology Palo Alto, CA 94304, USA
* Lipid Metabolism, Palo Alto, CA 94304, USA
Kennedy Institute of Rheumatology London
Correspondence to:
Correspondence to: J. Freire-Moar, Roche Bioscience (S3-6), 3401 Hillview Avenue, Palo Alto, CA 94303, USA.
An inducible form of cyclooxygenase-2 (COX-2) has been shown to be upregulated in vitro by various pro-inflammatory agents, such as lipopolysaccharide, IL-1 and TNF. COX-2 appears to be responsible for the increase in prostaglandin synthesis at the site of inflammation. To examine the involvement of COX-2 in inflammation, we analysed the expression of this gene in human rheumatoid arthritis (RA) and in rat adjuvant-induced arthritis. Immunocytochemical studies of synovial membrane biopsies from human RA, osteoarthritic (OA) and normal joints using a COX-2 specific antibody showed positive staining in RA, but not in normal synovial membranes. Specifically, expression of COX-2 was detected in synovial lining cells, lymphoid aggregates and endothelial cells of blood vessels. Although some positive staining was observed in the OA joints, the number of stained cells was dramatically lower and the staining of the cells was less intense than in the rheumatoid tissue. By reverse transcription and polymerase chain reaction analysis, COX-2 mRNA was detected in the rat adjuvant arthritic limb, whereas no COX-2 mRNA was detectable in the normal limb. These observations indicate that COX-2 expression is upregulated in inflammatory joint disease and that COX-2 is a potential therapeutic target for specific inhibition.
KEY WORDS: Rheumatoid arthritis, Adjuvant-induced arthritis, Synovial membrane, Immunohistochemistry, Prostaglandin synthase, Inflammation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. R. Healy, F. Zhu, J. D. Stull, and K. Konstantopoulos Elucidation of the signaling network of COX-2 induction in sheared chondrocytes: COX-2 is induced via a Rac/MEKK1/MKK7/JNK2/c-Jun-C/EBP{beta}-dependent pathway Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1146 - C1157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Mitchell, R. Lucas, I. Vojnovic, K. Hasan, J. R. Pepper, and T. D. Warner Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events FASEB J, December 1, 2006; 20(14): 2468 - 2475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Chillingworth, S. G. Morham, and L. F. Donaldson Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R327 - R334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Volgina, P.-C. Yam, and K. L. Knight A negative regulatory element in the rabbit 3'IgH chromosomal region Int. Immunol., August 1, 2005; 17(8): 973 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Egan, J. C. Lockhart, and W. R. Ferrell Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation J. Physiol., June 1, 2004; 557(2): 635 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N A Mohammed, S A El-Aleem, H A El-Hafiz, and R F T McMahon Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis J. Clin. Pathol., April 1, 2004; 57(4): 350 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lucas, C. Giannini, M. V. D'auria, and M. Paya Modulatory Effect of Bolinaquinone, a Marine Sesquiterpenoid, on Acute and Chronic Inflammatory Processes J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1172 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Mastbergen, F. P. J. G. Lafeber, and J. W. J. Bijlsma Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage Rheumatology, July 1, 2002; 41(7): 801 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. V. Mello, D. M. Barros, A. S. F. Silva, I. M. M. Laurindo, and G. S. Novaes Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis Rheumatology, May 1, 2000; 39(5): 533 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Lipsky, P. Brooks, L. J. Crofford, R. DuBois, D. Graham, L. S. Simon, L. B. A. van de Putte, and S. B. Abramson Unresolved Issues in the Role of Cyclooxygenase-2 in Normal Physiologic Processes and Disease Arch Intern Med, April 10, 2000; 160(7): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shamma, H. Yamamoto, Y. Doki, J. Okami, M. Kondo, Y. Fujiwara, M. Yano, M. Inoue, N. Matsuura, H. Shiozaki, et al. Up-Regulation of Cyclooxygenase-2 in Squamous Carcinogenesis of the Esophagus Clin. Cancer Res., April 1, 2000; 6(4): 1229 - 1238. [Abstract] [Full Text]
|
|
|
|
|
|
M. Kondo, H. Yamamoto, H. Nagano, J. Okami, Y. Ito, J. Shimizu, H. Eguchi, A. Miyamoto, K. Dono, K. Umeshita, et al. Increased Expression of COX-2 in Nontumor Liver Tissue Is Associated with Shorter Disease-free Survival in Patients with Hepatocellular Carcinoma Clin. Cancer Res., December 1, 1999; 5(12): 4005 - 4012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Okami, H. Yamamoto, Y. Fujiwara, M. Tsujie, M. Kondo, S. Noura, S. Oshima, H. Nagano, K. Dono, K. Umeshita, et al. Overexpression of Cyclooxygenase-2 in Carcinoma of the Pancreas Clin. Cancer Res., August 1, 1999; 5(8): 2018 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Dubois, S. B. Abramson, L. Crofford, R. A. Gupta, L. S. Simon, L. B. A. van de putte, and P. E. Lipsky Cyclooxygenase in biology and disease FASEB J, September 1, 1998; 12(12): 1063 - 1073. [Abstract] [Full Text]
|
|
|
|
 |
|
 O. S Jamal, P. G Conaghan, A. M Cunningham, P. M Brooks, V. F Munro, and K. F Scott Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium Ann Rheum Dis, September 1, 1998; 57(9): 550 - 558. [Abstract] [Full Text]
|
|